Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

RiboGene receives further funding for HCV

Oct. 18, 1996

Joint venture to develop Exten's artificial liver technology

Oct. 18, 1996

Tokyo Tanabe discloses agents for the treatment of diarrhea

Oct. 18, 1996

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Astra-CSL collaboration for H. pylori immunotherapeutic

Oct. 18, 1996

Gastric antisecretory agents disclosed by Il-Yang

Oct. 18, 1996

Yamanouchi reports on GI drugs in development

Oct. 11, 1996

Gastrointestinal drugs in the pipeline at Fujisawa

Oct. 11, 1996

Axcan acquires enzyme preparation for pancreatic insufficiency

Oct. 11, 1996

Promising results from U.S. trial on Zadaxin for hepatitis C

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...